Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 infection can significantly cause temporary hair loss.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

Chronic telogen effluvium is a common hair loss condition with specific characteristics and treatment options.

Critically ill patients may experience temporary hair loss after a fever.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Older female squirrel monkeys often experience a type of hair loss similar to chronic telogen effluvium in humans.

CTE and FPHL are different hair loss types with unique causes.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

CTE can distort results in hair growth trials, so exclude it carefully.

COVID-19 may cause early hair loss by infecting hair follicles.